Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 8c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.64), $0.08 better than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Nayax Ltd. (NYAX) Misses Q2 EPS by 39c; reaffirms guidance
• L.B. Foster (FSTR) Misses Q2 EPS by 20c ; Offers Guidance
• Motorcar Parts of America (MPAA) Misses Q1 EPS by 90c ; Offers Guidance